Ultragenyx Pharmaceutical Inc. buy Bank of America Co.
Start price
02.01.26
/
50%
€19.80
Target price
02.01.27
€49.31
Performance (%)
-3.96%
Price
05.06.26
€19.98
Summary
This prediction is currently active. With a performance of -3.96%, the BUY prediction for Ultragenyx Pharmaceutical Inc. by Bank_of_America_Co_ is down slightly. This prediction currently runs until 02.01.27. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | -1.818% | -1.818% |
| iShares Core DAX® | -1.862% | 0.670% |
| iShares Nasdaq 100 | -3.322% | 4.989% |
| iShares Nikkei 225® | -2.299% | 6.129% |
| iShares S&P 500 | -1.313% | 3.399% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical (NASDAQ:RARE) had its price target lowered by analysts at Bank of America Corporation from $72.00 to $58.00. They now have a "buy" rating on the stock.
Ratings data for RARE provided by MarketBeat
Stopped prediction by Bank_of_America_Co_ for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€37.00
31.05.24
31.05.24
€70.03
31.05.25
31.05.25
-20.00%
01.06.25
01.06.25
